Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromatherapy for Symptoms in Stem Cell Transplant
NCT05251337Phase 2Completed
- Sponsor
- Indiana University
- Start
- Mar 2022
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (4 arms), sponsored by Indiana University. Primary endpoints: Chemotherapy-induced Nausea, Vomiting, and Retching Symptoms at 48 hours and Anxiety Symptoms at 48 hours. Started Mar 2022; status: completed.
Beyond the preview
Go deeper on NCT05251337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05251337.